CallItPoll

← All events · Results archive · My picks

GlobalFinancials

FDA decision: Lorundrostat by Mineralys Therapeutics (on or before December 22, 2026)

If the FDA's decision on Lorundrostat by Mineralys Therapeutics on or before December 22, 2026 is a full approval or an accelerated approval, the answer is Yes.

What's your call?

Yes
No

Nobody has called this yet. Yours could be the first. Voting closes Dec 23.

Be the first to vote

Question and outcome: Kalshi. CallItPoll is not affiliated with Kalshi and runs no betting or trading.

More polls

Arizona Iced Tea price increase in 2026?Global · Financials · Be the firstVote →Spotify Premium Family Plan price increase this year?Global · Financials · Be the firstVote →Spotify Premium Duo Plan price increase this year?Global · Financials · Be the firstVote →Spotify Premium Individual Plan price increase this year?Global · Financials · Be the firstVote →Claude Pro price increase this year?Global · Financials · Be the firstVote →Netflix price increase this year?Global · Financials · Be the firstVote →

About this poll

This is a forecast question with a clear answer. Voting closes on Wednesday, December 23, 2026 at 4:59 AM UTC. When it settles, the outcome is recorded here from the question's public source and every call is marked right or wrong.

Type
Forecast question
Topic
Financials
Voting closes
Wednesday, December 23, 2026 at 4:59 AM UTC
Status
Open for predictions
Options
Yes, No
Source
Kalshi

One vote per network, no sign-up and no account. Results are real counts of real votes, updated as they arrive. How CallItPoll works · Results archive